Inventor · disambiguated record
Ashok Perumal
Also filed as: PERUMAL ASHOK
25 granted patents·13 pending applications·941 citations·filing 2008–2025
97Inventor score
Top patents by PatentIndex Score
38 records- 0198US10857143B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2019·Granted Dec 8, 2020·45 cites·27 claims
- 0298US10507203B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2018·Granted Dec 17, 2019·42 cites·19 claims
- 0398US9844545B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2017·Granted Dec 19, 2017·43 cites·30 claims
- 0498US9844544B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Dec 19, 2017·46 cites·40 claims
- 0598US9545399B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Jan 17, 2017·50 cites·27 claims
- 0698US9295642B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Mar 29, 2016·61 cites·29 claims
- 0798US9180100B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Nov 10, 2015·55 cites·30 claims
- 0898US9040083B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted May 26, 2015·51 cites·22 claims
- 0998US8999386B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2014·Granted Apr 7, 2015·56 cites·30 claims
- 1098US8956649B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted Feb 17, 2015·51 cites·43 claims
- 1198US8778390B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Jul 15, 2014·62 cites·30 claims
- 1298US8563033B1Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Oct 22, 2013·67 cites·19 claims
- 1398US8465765B2Orally effective methylphenidate extended release powder and aqueous suspension productMEHTA KETAN·Filed 2012·Granted Jun 18, 2013·71 cites·30 claims
- 1498US8287903B2Orally effective methylphenidate extended release powder and aqueous suspension productMEHTA KETAN·Filed 2011·Granted Oct 16, 2012·88 cites·30 claims
- 1597US11103494B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Aug 31, 2021·5 cites·30 claims
- 1697US11103495B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2021·Granted Aug 31, 2021·5 cites·30 claims
- 1796US8202542B1Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatingsMEHTA KETAN·Filed 2008·Granted Jun 19, 2012·132 cites·25 claims
- 1895US11433046B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2021·Granted Sep 6, 2022·3 cites·17 claims
- 1994US11911362B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2023·Granted Feb 27, 2024·1 cites·20 claims
- 2093US12343372B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·2 cites·29 claims
- 2193US12214010B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted Feb 4, 2025·2 cites·22 claims
- 2293US11826343B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2023·Granted Nov 28, 2023·1 cites·19 claims
- 2393US11633374B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·2 cites·20 claims
- 2488US12290503B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted May 6, 2025·0 cites·19 claims
- 2587US2023233542A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2023·Application pending·0 cites
- 2680US2025275941A1Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2777US11633389B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Apr 25, 2023·0 cites·30 claims
- 2873US2021169844A1Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2972US2017319566A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2017·Application pending·0 cites
- 3065US2025144106A1Ready to use non-aqueous solutions of lamotrigineTULEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3163US2017042874A1Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension ProductTRIS PHARMA INC·Filed 2016·Application pending·0 cites
- 3263US2017042873A1Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2016·Application pending·0 cites
- 3361US2025134883A1Novel compositionsTULEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3459US2015182469A1Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension ProductTRIS PHARMA INC·Filed 2015·Application pending·0 cites
- 3558US2024299307A1Extended-release compositions comprising atomoxetineTULEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3654US2012148672A1Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatingsMEHTA KETAN·Filed 2012·Application pending·0 cites
- 3754US2023372328A1Oral delayed burst formulation of low-dose naltrexone and methods for treating fibromyalgia and long covidSCILEX HOLDING COMPANY·Filed 2023·Application pending·0 cites
- 3844US2022265566A1Atovaquone nanoparticulate compositionsTULEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ashok Perumal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →